IMMUNOLOGICAL CHARACTERIZATION OF BONE MARROW-DERIVED MESENCHYMAL STROMAL CELLS FROM PATIENTS WITH CROHN’S DISEASE

(1) CLINICA MEDICA I

(2) ONCO-EMATOLOGIA PEDIATRICA

(3) SERVIZIO IMMUNOTRASFUSIONALE



This item was part of the New approaches to IBD therapy: Stem cells and other agents session at Gastro 2009 UEGW/WCOG London (17th UEGW)

This item can be cited as: Gut 2009; 58 (Suppl II) A10